Mechanisms of angiogenesis:: clinical and therapeutic applications.

被引:10
作者
Couffinhal, T
Dufourcq, P
Daret, D
Duplaà, C
机构
[1] Hop Cardiol, Serv Cardiol & Malad Vasc, F-33604 Pessac, France
[2] Inserm U441, F-33600 Pessac, France
来源
REVUE DE MEDECINE INTERNE | 2001年 / 22卷 / 11期
关键词
angiogenesis; endothelial cell; smooth muscle cell; tumor; myocardial ischemia;
D O I
10.1016/S0248-8663(01)00472-6
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose. - Endothelial and smooth muscle cells interact with each other to form new blood vessels. In this review, the cellular and molecular mechanism underlying the formation of the primary vascular plexus (vasculogenesis), the sprouting of further blood vessels (angiogenesis) and their maturation via recruitment of smooth muscle cells (arteriogenesis) during physiological and pathological conditions are summarized. Current knowledge and key point. - The concept of angiogenesis is studied in tumoral and cardiovascular pathology. Promoting the formation of new collateral vessels in ischemic tissues using angiogenic growth factors (therapeutic angiogenesis) is a promising approach in cardiovascular diseases. Conversely, inhibition of the action of key regulators of angiogenesis is a new pathway for the treatment of solid tumors and metastasis. Future prospects and projects. - These concepts are being tested now in clinical trials in the oncology or cardiovascular fields. Some trials are reported in this review with their potential adverse effects, limits and developments in the future. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:1064 / 1082
页数:19
相关论文
共 86 条
[1]
Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb [J].
Arras, M ;
Ito, WD ;
Scholz, D ;
Winkler, B ;
Schaper, J ;
Schaper, W .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01) :40-50
[2]
Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins [J].
Bader, BL ;
Rayburn, H ;
Crowley, D ;
Hynes, RO .
CELL, 1998, 95 (04) :507-519
[3]
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].
Baumgartner, I ;
Pieczek, A ;
Manor, O ;
Blair, R ;
Kearney, M ;
Walsh, K ;
Isner, JM .
CIRCULATION, 1998, 97 (12) :1114-1123
[4]
Medical progress: Advances in coronary angioplasty [J].
Bittl, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (17) :1290-1302
[5]
Isolation of endothelial cells and their progenitor cells from human peripheral blood [J].
Boyer, M ;
Townsend, LE ;
Vogel, LM ;
Falk, J ;
Reitz-Vick, D ;
Trevor, KT ;
Villalba, M ;
Bendick, PJ ;
Glover, JL .
JOURNAL OF VASCULAR SURGERY, 2000, 31 (01) :181-189
[6]
INDIRECT ANGIOGENIC CYTOKINES UP-REGULATE VEGF AND BFGF GENE-EXPRESSION IN VASCULAR SMOOTH-MUSCLE CELLS, WHEREAS HYPOXIA UP-REGULATES VEGF EXPRESSION ONLY [J].
BROGI, E ;
WU, TG ;
NAMIKI, A ;
ISNER, JM .
CIRCULATION, 1994, 90 (02) :649-652
[7]
REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[8]
INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[9]
Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[10]
Browder T, 2000, CANCER RES, V60, P1878